DON’T FORGET!
To ensure we share cutting-edge research & key discussions where they matter most, we will focus on other platforms & post less frequently here.
Stay connected!
Linkedin: https://t.co/OoDfioiJym
Instagram: https://t.co/NlysiGCDxY
Bluesky: https://t.co/f1LweaHfIe
Alors que la cérémonie @NobelPrize se tiendra aujourd'hui, notre commission scientifique a eu le privilège d’être invitée par @Transpl_Int à honorer les 3 lauréats du prix de Physiologie ou Médecine 2025, Mary Brunkow, Fred Ramsdell et Shimon Sakaguchi.
https://t.co/TEj0PNkce0
🚨 New paper alert in @Transpl_Int
🔑 Evolving Trends in Organ Donation and Transplantation Rates Across Muslim Majority Countries
🖍️ @IPATransplant_
‼️ Under-reported data/⬇️ donation/transplant activity/socio-economic versus religious barriers.
🔗 https://t.co/Q4LDts2ZYh
We are extremely excited to see our "Five Years Follow-up of Imlifidase Desensitized Kidney Transplant Recipients" published in @Transpl_Int! Available at: https://t.co/vJMwaRkTW1
Need a reminder about why the 2025 Nobel Prize in Physiology or Medicine is so important for Transplantation?
📖 Read the News & Views article by Julien Zuber and Hannah Kaminski (@hKminski) in @Transpl_Int now 👉 https://t.co/YRdJ3Zbtvl
@ESOTtransplant
🎉 Congrats to @Transpl_Int for an outstanding session at #ESOTcongress—highlighting top research!
👏 Kudos to @DrSamratRay & @shwaartz for their study on managing duodenal leaks after pancreas TX suggesting salvage strategies 🛟 may be safe.
📖 https://t.co/rbg6LHBjQ2
STAY TUNED!!
To ensure we share cutting-edge research & key discussions where they matter most, we will focus on other platforms & post less frequently here.
Stay connected!
Linkedin: https://t.co/OoDfioiJym
Instagram: https://t.co/NlysiGCDxY
Bluesky: https://t.co/f1LweaHfIe
STAY TUNED!!
To ensure we share cutting-edge research & key discussions where they matter most, we will focus on other platforms & post less frequently here.
Stay connected!
Linkedin: https://t.co/OoDfioiJym
Instagram: https://t.co/NlysiGCDxY
Bluesky: https://t.co/f1LweaHfIe
REMEMBER!!!
To ensure we share cutting-edge research & key discussions where they matter most, we will focus on other platforms & post less frequently here.
Stay connected!
Linkedin: https://t.co/OoDfioiJym
Instagram: https://t.co/NlysiGCDxY
Bluesky: https://t.co/f1LweaHfIe
STAY TUNED!!
To ensure we share cutting-edge research & key discussions where they matter most, we will focus on other platforms & post less frequently here.
Stay connected!
Linkedin: https://t.co/OoDfioiJym
Instagram: https://t.co/NlysiGCDxY
Bluesky: https://t.co/f1LweaHfIe
WHAT’S NEW?
To ensure we share cutting-edge research & key discussions where they matter most, we will focus on other platforms & post less frequently here.
Stay connected!
Linkedin: https://t.co/OoDfioiJym
Instagram: https://t.co/NlysiGCDxY
Bluesky: https://t.co/f1LweaHfIe
REMEMBER!
To ensure we share cutting-edge research & key discussions where they matter most, we will focus on other platforms & post less frequently here.
Stay connected!
Linkedin: https://t.co/OoDfioiJym
Instagram: https://t.co/NlysiGCDxY
Bluesky: https://t.co/f1LweaHfIe
DID YOU DO IT?
To ensure we share cutting-edge research & key discussions where they matter most, we will focus on other platforms & post less frequently here.
Stay connected!
Linkedin: https://t.co/OoDfioiJym
Instagram: https://t.co/NlysiGCDxY
Bluesky: https://t.co/f1LweaHfIe
DON’T FORGET!
To ensure we share cutting-edge research & key discussions where they matter most, we will focus on other platforms & post less frequently here.
Stay connected!
Linkedin: https://t.co/OoDfioiJym
Instagram: https://t.co/NlysiGCDxY
Bluesky: https://t.co/f1LweaHfIe
DON’T FORGET!
To ensure we share cutting-edge research & key discussions where they matter most, we will focus on other platforms & post less frequently here.
Stay connected!
Linkedin: https://t.co/OoDfioiJym
Instagram: https://t.co/NlysiGCDxY
Bluesky: https://t.co/f1LweaHfIe
📖 Read the full publication & see the visual abstract:
Frontiers Publishing Partnerships | Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus
Register here: https://t.co/ZQtMzqJbek
(6/6)
📢 Join our next @Transplant International Journal Club!
We’ll dive into a Delphi consensus on imlifidase for HLA-incompatible kidney transplantation in highly sensitized patients. 🏥💉 #Transplantation#KidneyTransplant (1/6)
Register here: https://t.co/ZQtMzqJbek
📅 Mark your calendar!
🗓 March 17, 2025 – 17:00 CET
📍 Live Zoom Session (45 min)
👥 Open to all, esp. young transplant professionals!
Don’t miss this chance to engage with top experts on a cutting-edge topic!
Register here: https://t.co/ZQtMzqJbek
(5/6)